Journal of Neurology and Experimental Neuroscience

Federica Peci, Rosjana Pica and Samorindo Peci   Abstract   Objective: The aim of this study is to investigate whether a 4-week phys¬iotherapeutic rehabilitation combined with transcranial photobiomodulation (tPBM) treatment is more effective than the…

Sreeja Namilakonda, Sindhu Priya Botta,and Jannu Nikshiptha
Dabigatran is a non-vitamin K antagonist oral anticoagulant (NOAC) whose widespread use for various indications has increased. Intracranial bleed in patients receiving dabigatran is a rare occurrence but can be fatal if reversible agent Idarucizumab is not administered immediately to reverse its effects.

Sean Tok, Dries Crauwels and Wilhelmus Drinkenburg
Patients suffering from Alzheimer’s disease (AD) exhibit an increased risk for developing seizures and epileptiform activity, especially at the later stages of the disease.

Aasheeta Parikh Bawa and Yonghua Zhang
Many patients present to a neurologist due to rapidly progressive dementia (RPD). One rare etiology is Creutzfeldt–Jakob disease (CJD), a neurological disorder that occurs in one to two people per one million population.

Abhinay Reddy Koppula, Dudekonda Sai Sandeep and Tekuru Yogesh
Hepatic Encephalopathy (H.E), defined as a spectrum of neuropsychiatric abnormalities in patients with severe liver dysfunction. It is a most common complication of advanced liver disease with significant incidence and death rate [1].